XML 32 R20.htm IDEA: XBRL DOCUMENT
v3.25.3

Leases | 9 Months Ended
--- | ---
Sep. 30, 2025
Leases [Abstract] |
Leases | Leases As Lessee The Company’s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next six years. The Company’s leases do not contain any restrictive covenants. The Company’s office leases generally contain renewal options for periods ranging from one to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company’s office leases do not contain any material residual value guarantees. The Company’s equipment leases generally do not contain renewal options. Payments due under the Company’s operating leases include fixed payments as well as variable payments. For the Company’s office leases, variable payments include amounts for the Company’s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company’s equipment leases, variable payments may consist of sales taxes, property taxes and other fees. The components of lease costs for the three and nine months ended September 30, 2025 and 2024 are as follows (in thousands):
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Operating lease cost |  | $ | 488 |  |  | $ | 478 |  |  | $ | 1,504 |  |  | $ | 1,423 |
Variable lease cost |  | 123 |  |  | 94 |  |  | 383 |  |  | 266 |
Total lease cost |  | $ | 611 |  |  | $ | 572 |  |  | $ | 1,887 |  |  | $ | 1,689 |
Supplemental cash flow information and non-cash activity related to the Company’s leases are as follows (in thousands):
|  | Nine Months Ended September 30,
|  | 2025 |  | 2024
Cash paid for amounts included in the measurement of lease liabilities and right of use assets: |  |  |  |
Operating cash flow from operating leases |  | $ | 1,553 |  |  | $ | 1,400 |
Right of use assets obtained in exchange for lease obligations: |  |  |  |
Operating leases |  | $ | 37 |  |  | $ | 250 |
Increases to right of use assets resulting from lease modifications: |  |  |  |
Operating leases |  | $ | 344 |  |  | $ | — |
Weighted average remaining lease terms and discount rates for the Company’s operating leases are as follows:
|  | As of September 30,
|  | 2025 |  | 2024
|  | Years |  | Years
Weighted average remaining lease term: |  | 4.7 |  | 5.6
|  | Rate |  | Rate
Weighted average discount rate: |  | 7.6% |  | 7.8%
Future maturities of lease liabilities as of September 30, 2025 are as follows (in thousands):
|  | Operating Leases |  |
2025 |  | $ | 474 |  |  |
2026 |  | 1,903 |  |  |
2027 |  | 1,627 |  |  |
2028 |  | 1,504 |  |  |
2029 |  | 1,396 |  |  |
2030 and thereafter |  | 1,091 |  |  |
Total undiscounted lease payments |  | 7,995 |  |  |
Less: Imputed interest |  | (2,819) |  |  |
Total lease liabilities |  | $ | 5,176 |  |  |
The long-term portion of the lease liabilities included in the amounts above is $3.8 million with the remainder included in other current liabilities in the condensed consolidated balance sheets. As Lessor: We lease medical equipment to customers, often in conjunction with arrangements to provide consumable medical products. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options, varies by customer. The Company elected the “combining lease and non-lease components” practical expedient for all qualifying non-lease components. The components of the Company’s lease revenues consisted of the following (in thousands ) for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Net operating lease revenue | $ | 7,443 |  |  | $ | 7,242 |  |  | $ | 22,825 |  |  | $ | 20,225 |
Sales-type lease revenue | 83 |  |  | 129 |  |  | 270 |  |  | 530 |
Total lease revenue | $ | 7,526 |  |  | $ | 7,371 |  |  | $ | 23,095 |  |  | $ | 20,755 |
The components of our net investment in sales-type leases as of September 30, 2025 and December 31, 2024 were (in thousands):
| September 30, 2025 |  | December 31, 2024 |
Lease receivable | $ | 1,146 |  |  | $ | 1,934 |  |
Net investment in leases | $ | 1,146 |  |  | $ | 1,934 |  |
Our net investment in sales-type leases is classified as follows in the accompanying condensed consolidated balance sheets as of September 30, 2025 and December 31, 2024 were (in thousands):
| September 30, 2025 |  | December 31, 2024
Accounts receivable, net | $ | 964 |  |  | $ | 1,207 |
Other assets | 182 |  |  | 727 |
Total | $ | 1,146 |  |  | $ | 1,934 |
Future maturities of sales-type leases as of September 30, 2025 are as follows (in thousands):
|  | Sales-Type Leases
2025 |  | $ | 356 |
2026 |  | 747 |
2027 |  | 120 |
2028 |  | 16 |
2029 |  | — |
Thereafter |  | — |
Total undiscounted lease payments |  | 1,239 |
Less: Imputed interest |  | (93) |
Total lease receivables |  | $ | 1,146 |
Leases | Leases As Lessee The Company’s operating leases are primarily for office space, service facility centers and equipment under operating lease arrangements that expire at various dates over the next six years. The Company’s leases do not contain any restrictive covenants. The Company’s office leases generally contain renewal options for periods ranging from one to five years. Because the Company is not reasonably certain to exercise these renewal options, the options are not considered in determining the lease term, and payments associated with the option years are excluded from lease payments. The Company’s office leases do not contain any material residual value guarantees. The Company’s equipment leases generally do not contain renewal options. Payments due under the Company’s operating leases include fixed payments as well as variable payments. For the Company’s office leases, variable payments include amounts for the Company’s proportionate share of operating expenses, utilities, property taxes, insurance, common area maintenance and other facility-related expenses. For the Company’s equipment leases, variable payments may consist of sales taxes, property taxes and other fees. The components of lease costs for the three and nine months ended September 30, 2025 and 2024 are as follows (in thousands):
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
Operating lease cost |  | $ | 488 |  |  | $ | 478 |  |  | $ | 1,504 |  |  | $ | 1,423 |
Variable lease cost |  | 123 |  |  | 94 |  |  | 383 |  |  | 266 |
Total lease cost |  | $ | 611 |  |  | $ | 572 |  |  | $ | 1,887 |  |  | $ | 1,689 |
Supplemental cash flow information and non-cash activity related to the Company’s leases are as follows (in thousands):
|  | Nine Months Ended September 30,
|  | 2025 |  | 2024
Cash paid for amounts included in the measurement of lease liabilities and right of use assets: |  |  |  |
Operating cash flow from operating leases |  | $ | 1,553 |  |  | $ | 1,400 |
Right of use assets obtained in exchange for lease obligations: |  |  |  |
Operating leases |  | $ | 37 |  |  | $ | 250 |
Increases to right of use assets resulting from lease modifications: |  |  |  |
Operating leases |  | $ | 344 |  |  | $ | — |
Weighted average remaining lease terms and discount rates for the Company’s operating leases are as follows:
|  | As of September 30,
|  | 2025 |  | 2024
|  | Years |  | Years
Weighted average remaining lease term: |  | 4.7 |  | 5.6
|  | Rate |  | Rate
Weighted average discount rate: |  | 7.6% |  | 7.8%
Future maturities of lease liabilities as of September 30, 2025 are as follows (in thousands):
|  | Operating Leases |  |
2025 |  | $ | 474 |  |  |
2026 |  | 1,903 |  |  |
2027 |  | 1,627 |  |  |
2028 |  | 1,504 |  |  |
2029 |  | 1,396 |  |  |
2030 and thereafter |  | 1,091 |  |  |
Total undiscounted lease payments |  | 7,995 |  |  |
Less: Imputed interest |  | (2,819) |  |  |
Total lease liabilities |  | $ | 5,176 |  |  |
The long-term portion of the lease liabilities included in the amounts above is $3.8 million with the remainder included in other current liabilities in the condensed consolidated balance sheets. As Lessor: We lease medical equipment to customers, often in conjunction with arrangements to provide consumable medical products. Certain of our equipment leases are classified as sales-type leases and the remainder are operating leases. The terms of the related contracts, including the proportion of fixed versus variable payments and any options, varies by customer. The Company elected the “combining lease and non-lease components” practical expedient for all qualifying non-lease components. The components of the Company’s lease revenues consisted of the following (in thousands ) for the three and nine months ended September 30, 2025 and 2024:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2025 |  | 2024 |  | 2025 |  | 2024
Net operating lease revenue | $ | 7,443 |  |  | $ | 7,242 |  |  | $ | 22,825 |  |  | $ | 20,225 |
Sales-type lease revenue | 83 |  |  | 129 |  |  | 270 |  |  | 530 |
Total lease revenue | $ | 7,526 |  |  | $ | 7,371 |  |  | $ | 23,095 |  |  | $ | 20,755 |
The components of our net investment in sales-type leases as of September 30, 2025 and December 31, 2024 were (in thousands):
| September 30, 2025 |  | December 31, 2024 |
Lease receivable | $ | 1,146 |  |  | $ | 1,934 |  |
Net investment in leases | $ | 1,146 |  |  | $ | 1,934 |  |
Our net investment in sales-type leases is classified as follows in the accompanying condensed consolidated balance sheets as of September 30, 2025 and December 31, 2024 were (in thousands):
| September 30, 2025 |  | December 31, 2024
Accounts receivable, net | $ | 964 |  |  | $ | 1,207 |
Other assets | 182 |  |  | 727 |
Total | $ | 1,146 |  |  | $ | 1,934 |
Future maturities of sales-type leases as of September 30, 2025 are as follows (in thousands):
|  | Sales-Type Leases
2025 |  | $ | 356 |
2026 |  | 747 |
2027 |  | 120 |
2028 |  | 16 |
2029 |  | — |
Thereafter |  | — |
Total undiscounted lease payments |  | 1,239 |
Less: Imputed interest |  | (93) |
Total lease receivables |  | $ | 1,146 |

X
- References No definition available. + Details
Name: | us-gaap_LeasesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/842-20/tableOfContent + Details
Name: | us-gaap_LesseeOperatingLeasesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for lessor's operating leases. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 842 -SubTopic 30 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/842-30/tableOfContent + Details
Name: | us-gaap_OperatingLeasesOfLessorDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration